Propanc Biopharma, Inc Common Stock
Price & Volume
Stats
See more52W Range | $1.65-$315 |
Market Cap | $1.7M |
Shares Short | 50,470 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$176.20 |
News
See moreYahoo Finance • 4 months ago
Propanc Biopharma Signs MOU With Avance To Advance Phase 1b, FIH Of PRP In Solid Tumours; Stock Down
Yahoo Finance • 5 months ago
Propanc Biopharma’s CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study
Yahoo Finance • 5 months ago
Pre-Market Movers: BYAH, LXEO, ELTX Swing Big
Yahoo Finance • 5 months ago
ShareStructure.io Announces Investor Education Platform on Public Company Financing Activity.
About
CEO | Mr. James Nathanielsz |
Address | 302, 6 Butler Street, Camberwell, VIC, Australia, 3124 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 2 |